EUVIMEDOpdag EUVIMED
Klinische Studie (Phase III)Multizentrische StudieRandomisierte kontrollierte StudieOpen access · CC BY 4.0

Effect of Delgocitinib Cream on Health‐Related Quality of Life in Patients With Moderate to Severe Chronic Hand Eczema

Andrea Bauer, Lyn Guenther, Richard Woolf, Eydna Didriksen Apol iD, Douglas Maslin, Nanna Nyholm, Henrik Thoning, Marie Louise Schuttelaar iD

Contact Dermatitis · 2026-07 · 95 (1) · 91-99

DOI: 10.1111/cod.70114 ↗

At a glance

Klinische Studie (Phase III) in Contact Dermatitis, published online on 2026-03-03. Written by Andrea Bauer and 7 co-authors. Institution: Department of Dermatology, University Allergy Centre, University Hospital Carl Gustav Carus, Technical University, Dresden, Germany. Major MEDLINE topics: Dermatologic Agents, Eczema, Hand Dermatoses, Pyrroles. Cited 1 times so far (Crossref); 34 references. The full text is freely available (open access, CC BY 4.0). Funded by: LEO Pharma.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Chronic Hand Eczema (CHE) is a multifactorial, fluctuating inflammatory disease of the hands and wrists that negatively impacts patients' health‐related quality of life (HRQoL).

Objectives

To assess the effects of delgocitinib cream versus cream vehicle on HRQoL.

Methods

DELTA 1 and DELTA 2 were phase 3 trials of identical design in which adults with moderate to severe CHE were randomised (2:1) to double‐blind treatment with delgocitinib cream 20 mg/g or cream vehicle twice daily for 16 weeks. Data were pooled from both trials and changes in EQ‐5D, Dermatology Life Quality Index (DLQI), and Hand Eczema Impact Scale (HEIS), including the HEIS Proximal Daily Activity Limitations (PDAL) and HEIS Embarrassment (Emb) subsets, were compared.

Results

Across the two trials, 639 patients were randomised to delgocitinib cream and 321 to cream vehicle. Delgocitinib cream resulted in significantly greater improvement in EQ‐5D, DLQI, HEIS, HEIS PDAL, and HEIS Emb compared with cream vehicle at week 16 (all p < 0.001). More patients achieved clinically meaningful improvement from baseline in patient‐reported outcomes at week 16 (all p < 0.001), and the mean time spent in an improved HRQoL state increased with delgocitinib cream.

Conclusions

Delgocitinib cream resulted in clinically significant improvement in HRQoL compared with cream vehicle. Clinical Trial ID DELTA 1 (NCT04871711) and DELTA 2 (NCT04872101).

Subjects

MeSH terms (MEDLINE)

Dermatologic AgentsEczemaHand DermatosesPyrrolesQuality of LifeAdultAgedFemaleHumansMaleMiddle AgedChronic DiseaseDouble-Blind MethodSeverity of Illness IndexSkin CreamTreatment Outcome

Author keywords

contact dermatitiseczemahand eczema impact scalehealth‐related quality of life

Substances

delgocitinibDermatologic AgentsPyrroles

Authors and institutions

  • Department of Dermatology, University Allergy Centre, University Hospital Carl Gustav Carus, Technical University, Dresden, Germany.
  • Division of Dermatology, Department of Medicine, Western University, London, Ontario, Canada.
  • St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • LEO Pharma A/S, Ballerup, Denmark.
  • Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

ORCID profiles: Eydna Didriksen Apol, Marie Louise Schuttelaar

Funding

  • LEO Pharma

Cite

APA

Bauer, A., Guenther, L., Woolf, R., Didriksen Apol, E., Maslin, D., Nyholm, N., Thoning, H., & Schuttelaar, M. L. (2026). Effect of Delgocitinib Cream on Health‐Related Quality of Life in Patients With Moderate to Severe Chronic Hand Eczema. Contact Dermatitis, 95(1), 91-99. https://doi.org/10.1111/cod.70114

Vancouver

Bauer A, Guenther L, Woolf R, Didriksen Apol E, Maslin D, Nyholm N, et al. Effect of Delgocitinib Cream on Health‐Related Quality of Life in Patients With Moderate to Severe Chronic Hand Eczema. Contact Dermatitis. 2026;95(1):91-99. doi:10.1111/cod.70114

BibTeX
@article{Bauer2026,
  author = {Bauer, Andrea and Guenther, Lyn and Woolf, Richard and Didriksen Apol, Eydna and Maslin, Douglas and Nyholm, Nanna and Thoning, Henrik and Schuttelaar, Marie Louise},
  title = {Effect of Delgocitinib Cream on Health‐Related Quality of Life in Patients With Moderate to Severe Chronic Hand Eczema},
  journal = {Contact Dermatitis},
  year = {2026},
  volume = {95},
  number = {1},
  pages = {91--99},
  doi = {10.1111/cod.70114}
}
Start for free →